CD274 and cancer: The PD-1/PD-L1 axis plays a key role in tumor immune evasion by suppressing T cell activation and promoting immune tolerance, thereby contributing to the establishment of an immunosuppressive TME, making PD-L1 as a crucial target in cancer immunotherapy.